Steve Macfarlane

Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University

Connect:

Steve Macfarlane

Those who received the active drug during the study progressed 27 per cent less compared to those who were given placebo over the 18 months.

What is lecanemab, the newly approved Alzheimer’s drug? Can it really slow down dementia?

Steve Macfarlane

30 Sep 2025

4 min read

Down To Earth

www.downtoearth.org.in